Member Info for Soupdragon78

Greggs, NFX hold the IP

Greggs, there is nothing stopping NFX licensing NXP001 with others anyway, this has always been the case. Yatai deal was China only and has a break clause that if they don’t pay then they don’t have licence to use the product.

All NFX are doing is trying to get the payment. But they can choose to walk away and go elsewhere, all they would be losing is income, not the product.

Always love these type of posts, usual ‘you have to be a mug to invest here’... ‘Dans failed and you can’t trust him’... ‘board members have left which tells you everything’

Followed by...

But I’m looking to buy in at....

Or

I still hold.

Lol!

Good job you’re not bitter ATrades.

With reference to the Ebers number of milestones, I think the wording of some parts of the RNS don't help and are slightly contradictory. So I do think there has been one milestone payment, but not any others which I think should read as new milestones to be achieved.

Looking at the section in detail again....

"Ebers Tech Strategic Cannabinoid Collaboration Update

We are pleased to confirm that as a result of on-going development activities under the previously announced strategic cannabinoid agreement with Ebers Tech, a further patent filing has been made in relation to novel cannabinoid cocrystals. This latest patent filing triggers an undisclosed development milestone payment. Further cannabinoids have been added to the agreement, triggering additional undisclosed milestones and remain under development, with the potential for further milestone payments to Nuformix in the near-term."

So, it says 'a further patent filing has been made' which is definitely written as singular, just one patent. Then is confirmed by "This latest patent filing triggers an undisclosed development milestone payment. " Which again is written as a single filing and single payment.

The confusion occurs with the word 'triggering' in the following

"Further cannabinoids have been added to the agreement, triggering additional undisclosed milestones and remain under development..."

I am reading the use of the word as they have created new milestones which have yet to be achieved, triggering isn't really the right word to use, although I can't think of an alternative.

The closing of that sentence reads "with the potential for further milestone payments to Nuformix in the near-term". Which confirms that milestones for these new items are in the future.

We know the original Ebers deal covered 9 co-crystals, this now has been expanded to further cannabinoid opportunities as NFX agreed to solely work for Ebers in this field.

A bit forensic I know, but not much else to do....

Sparkington, I posted the below on the other forum site explaining what revenues may be current. All guesstimates but trying to form some sort of logic.

We know from today’s ‘Business Update’ rns that the Vistagen collaboration included ‘immediate revenues’, so I was looking at how much cash Vistagen has to gauge what sort of payment might have been made.

From their filings, they had $4m after raising money at the end of January.

As the monies are a kick off to the collaboration they will be low to cover initial research. We know from both the Ebers and NSB work that NFX have been paid circa £500k for this type of work before.

Hence my thoughts, Vistagen would likely have paid a similar amount.

In terms of Ebers, the previous patent filing generated a milestone payment of £400k, and Dan has said that the big money will only come when testing occurs. So the news today about another patent application will likely have generated a similar income.

All my guesstimates but based on previous history of how the company operates, the positive is that these two payments combined, plus the money from the placing should cover this years costs to date.

Also worth noting that the company is still chasing the China money.

Tightening the spread, anything at 4.63 is a sell and above 4.7 is a buy.

LSE punters:

“We want news.... we want news!!”

**news**

“Not that news!”

Added 300k in two chunks at 4.37 and 4.4

Interesting change of narrative to now say they don’t know if they have legal avenues to get the China money.

Pointless comparison, if a bit amateur. Move on.

“The spark has gone”

Christ on a pedalo! Is this the marriage guidance forum now?

ATtrades, you previously said that people shouldn’t worry if they are holding till summer. Why the change?

If you are in sensitive contract talks do you...

A) answer the phone and tell anybody who wants to know exactly what’s going on so they can post it on a public bulletin board or twitter.

Or

B) keep info out of the public domain so as not to put negotiations at risk.

Investor1111, Sonnets simply asked if Keegan was still CEO at HOX.
A simple view of his linked in confirms that yes he is still CEO there and also he lists his work at NFX as part time non-Exec director.

Sonnets, Keegan is a part time non-exec at Nuformix.

Firstly we don’t even know they were talking to Kissei, that was just the rumour, the company announcement said ‘multiple parties’.

Secondly it defo won’t be covered in governmental talks.

Bunsen was pulling your plonker

Exactly Halespur, o/t I use zoom a bit through work but also whilst working from home looking after my 3 year old daughter, we did a music and theatre Zoom class yesterday morning that pre-lockdown she would go to in person. As an adult you Are only allowed on screen if you have your child with you at all times. They’ve brought this in after dirtbags trying to join in the the room. Seems Zoom is just crap at security.

They’ll happily let you sell 1m shares at 5.25p. Ridic!